May 1, 2013
By:
Rita Peters
Wanted: Aspiring authors to share technical and scientific solutions for biopharmaceutical processing.
|
March 1, 2013
By:
Rita Peters
A QbD paradigm advances process understanding in development and manufacturing.
|
January 1, 2013
By:
Angie Drakulich
Our editorial advisory board members provide their perspective on what's ahead in the biopharmaceutical industry.
|
December 1, 2012
By:
Angie Drakulich
Keeping tabs on crucial medicines should be part of consumers' and manufacturers' emergency-preparedness plans.
|
November 1, 2012
By:
Angie Drakulich
Global coordination tactics that incorporate online technologies and social media are reshaping disease prevention and response.
|
October 1, 2012
By:
Angie Drakulich
Will the next US President support the backbone of our industry?
|
July 1, 2012
By:
Angie Drakulich
Although FDA cannot do anything to stop drugs from being discontinued, it can do something about supply and quality problems that lead to shortages.
|
May 1, 2012
By:
Angie Drakulich
No matter the time or cost, knowing what's going on inside your facilities is always going to be worth the effort.
|
March 1, 2012
By:
Angie Drakulich
Has the long-awaited guidance answered all of the industry's questions?
|
|
